Latest Breaking News On - Dedicaid gmb - Page 1 : comparemela.com

Mauna Kea Technologies and Telix Pharmaceuticals to Expand Partnership in Uro-oncologic Surgery

13.11.2023 - Regulatory News: Telix Pharmaceuticals Limited (ASX: TLX, Telix) and Mauna Kea Technologies (Euronext Growth: ALMKT, Mauna Kea), today announced an expansion of the IRiS (Imaging and Robotics in Surgery) Alliance through a strategic €6 million . Seite 1

Cdx illuccixMauna kea cellvizioDedicaid gmbMauna keaDrug administrationTelix pharmaceuticals limitedHealth canadaRobotics in surgery allianceAustralian therapeutic goods administrationRegulatory newsPharmaceuticals limitedMauna kea technologiesEuronext growthLightpoint medicalDedicaid gmbhMauna kea technologieso chart

Telix Pharmaceuticals Limited: Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery

Telix Pharmaceuticals Limited: Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesFrance generalMauna keaKyahn williamsonSacha loiseauMauna kea cellvizioCdx illuccixCdx zircaixDedicaid gmbChristian behrenbruchHealth canadaAustralian therapeutic goods administrationAustralian securities exchangeCorporate communicationsPrnewswire telix pharmaceuticals limited

Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery

MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Paris-based Mauna Kea.

United kingdomFrance generalUnited statesCdx zircaixMauna keaSacha loiseauChristian behrenbruchKyahn williamsonDedicaid gmbCdx illuccixMauna kea cellvizioCorporate communicationsDrug administrationTelix pharmaceuticals limitedAustralian therapeutic goods administrationSurgery alliance

Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended 30 June 2023. All.

United statesUnited kingdomBruxelles capitaleDedicaid gmbChristian behrenbruchKyahn williamsonTelix pharmaceuticalsDrug administrationAustralian therapeutic goods administrationEuropean unionPrnewswire telix pharmaceuticals limitedAustralian securities exchangeHealth canadaTelix manufacturing solutionsPharmaceuticals limitedGrand pharmaceutical group limited

Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying.

United statesUnited kingdomBruxelles capitaleTelix illuccixDedicaid gmbhCdx illuccix clinicaltrialsKyahn williamsonDedicaid gmbMerck kgaTelix pharmaceuticalsTelix pharmaceuticals limitedHealth canadaGroup limited grand pharmaDrug administrationAccess programEuropean union